| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 53 | 2024 | 3204 | 5.690 |
Why?
|
| Smoke | 19 | 2022 | 235 | 4.500 |
Why?
|
| Respiratory Mucosa | 24 | 2021 | 439 | 4.290 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 19 | 2023 | 1406 | 3.520 |
Why?
|
| Bronchitis, Chronic | 6 | 2023 | 82 | 3.210 |
Why?
|
| Smoking | 37 | 2024 | 9053 | 2.750 |
Why?
|
| Epithelial Cells | 30 | 2023 | 3677 | 2.660 |
Why?
|
| Pulmonary Emphysema | 10 | 2024 | 684 | 2.300 |
Why?
|
| Lung | 48 | 2024 | 10002 | 2.240 |
Why?
|
| Forced Expiratory Volume | 19 | 2024 | 1814 | 2.050 |
Why?
|
| Wood | 8 | 2022 | 92 | 1.740 |
Why?
|
| Mitochondrial Proteins | 8 | 2023 | 976 | 1.640 |
Why?
|
| Emphysema | 3 | 2024 | 238 | 1.590 |
Why?
|
| Lipopolysaccharides | 18 | 2018 | 2206 | 1.590 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2017 | 2898 | 1.580 |
Why?
|
| Hyperplasia | 15 | 2021 | 1152 | 1.520 |
Why?
|
| Pneumonia | 10 | 2023 | 2143 | 1.460 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2022 | 366 | 1.410 |
Why?
|
| Interleukin-13 | 5 | 2018 | 392 | 1.340 |
Why?
|
| Apoptosis Regulatory Proteins | 11 | 2023 | 1136 | 1.340 |
Why?
|
| Sputum | 6 | 2021 | 506 | 1.200 |
Why?
|
| Goblet Cells | 7 | 2016 | 298 | 1.170 |
Why?
|
| Allergens | 13 | 2021 | 1432 | 1.150 |
Why?
|
| Bronchi | 15 | 2021 | 845 | 1.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 20 | 2018 | 755 | 1.100 |
Why?
|
| Metaplasia | 16 | 2016 | 322 | 1.010 |
Why?
|
| Health Status | 5 | 2018 | 4077 | 1.000 |
Why?
|
| Influenza A virus | 3 | 2023 | 458 | 0.980 |
Why?
|
| Mucus | 8 | 2016 | 341 | 0.980 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2024 | 254 | 0.960 |
Why?
|
| Uteroglobin | 5 | 2018 | 56 | 0.950 |
Why?
|
| Volatile Organic Compounds | 2 | 2022 | 86 | 0.950 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2917 | 0.940 |
Why?
|
| Apoptosis | 22 | 2023 | 9490 | 0.940 |
Why?
|
| Interferon-gamma | 10 | 2018 | 3162 | 0.940 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2008 | 282 | 0.900 |
Why?
|
| Hexosyltransferases | 1 | 2023 | 58 | 0.900 |
Why?
|
| Spirometry | 6 | 2023 | 929 | 0.880 |
Why?
|
| Mucin 5AC | 6 | 2018 | 96 | 0.820 |
Why?
|
| Autophagy | 4 | 2013 | 1327 | 0.810 |
Why?
|
| Casein Kinase II | 1 | 2021 | 122 | 0.750 |
Why?
|
| Rats, Inbred F344 | 15 | 2016 | 826 | 0.740 |
Why?
|
| Airway Remodeling | 3 | 2018 | 133 | 0.730 |
Why?
|
| Asthma | 15 | 2022 | 6234 | 0.720 |
Why?
|
| Vital Capacity | 7 | 2024 | 971 | 0.710 |
Why?
|
| Pyroglyphidae | 2 | 2018 | 89 | 0.690 |
Why?
|
| Animals | 103 | 2024 | 168475 | 0.690 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 150 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 27 | 2024 | 22174 | 0.660 |
Why?
|
| Air Pollutants | 6 | 2022 | 2896 | 0.660 |
Why?
|
| Mucins | 5 | 2022 | 568 | 0.660 |
Why?
|
| Genes, bcl-2 | 4 | 2011 | 119 | 0.650 |
Why?
|
| Inflammation | 17 | 2023 | 10774 | 0.650 |
Why?
|
| Hypersensitivity | 3 | 2018 | 1171 | 0.630 |
Why?
|
| Mucous Membrane | 6 | 2011 | 659 | 0.620 |
Why?
|
| Trachea | 11 | 2017 | 1089 | 0.620 |
Why?
|
| New Mexico | 7 | 2018 | 83 | 0.610 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2023 | 1321 | 0.610 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2024 | 220 | 0.610 |
Why?
|
| DNA Methylation | 10 | 2020 | 4399 | 0.600 |
Why?
|
| Membrane Proteins | 15 | 2020 | 7859 | 0.600 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 66 | 0.600 |
Why?
|
| Interleukin-9 | 2 | 2008 | 62 | 0.590 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2017 | 71 | 0.580 |
Why?
|
| Gene Expression | 10 | 2022 | 7581 | 0.580 |
Why?
|
| Endoplasmic Reticulum | 2 | 2017 | 1134 | 0.570 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2016 | 168 | 0.550 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2019 | 632 | 0.550 |
Why?
|
| Nasal Septum | 1 | 2018 | 130 | 0.540 |
Why?
|
| Mice | 51 | 2024 | 81539 | 0.540 |
Why?
|
| Poly I-C | 1 | 2016 | 112 | 0.530 |
Why?
|
| GATA4 Transcription Factor | 2 | 2014 | 124 | 0.530 |
Why?
|
| Ovalbumin | 9 | 2017 | 677 | 0.520 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1974 | 0.510 |
Why?
|
| Caspase 3 | 3 | 2016 | 731 | 0.500 |
Why?
|
| Lysosomes | 1 | 2020 | 924 | 0.480 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2016 | 473 | 0.480 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2016 | 477 | 0.480 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 1935 | 0.470 |
Why?
|
| Cough | 1 | 2018 | 594 | 0.460 |
Why?
|
| Cell Death | 5 | 2016 | 1679 | 0.450 |
Why?
|
| Anoikis | 1 | 2013 | 48 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 315 | 0.440 |
Why?
|
| Pulmonary Alveoli | 6 | 2021 | 652 | 0.440 |
Why?
|
| Weight Gain | 2 | 2014 | 2348 | 0.440 |
Why?
|
| Cytokines | 13 | 2023 | 7396 | 0.430 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 483 | 0.430 |
Why?
|
| Proteomics | 4 | 2024 | 3848 | 0.430 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2021 | 819 | 0.430 |
Why?
|
| RNA | 3 | 2020 | 2725 | 0.420 |
Why?
|
| Nasal Mucosa | 3 | 2004 | 416 | 0.420 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2021 | 0.410 |
Why?
|
| Genes, p53 | 1 | 2014 | 712 | 0.400 |
Why?
|
| Interleukin-17 | 1 | 2018 | 912 | 0.400 |
Why?
|
| ADAM Proteins | 3 | 2020 | 238 | 0.400 |
Why?
|
| Humans | 118 | 2024 | 761596 | 0.390 |
Why?
|
| Gene Expression Regulation | 11 | 2019 | 11904 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 8 | 2015 | 5790 | 0.380 |
Why?
|
| Lung Neoplasms | 12 | 2020 | 13381 | 0.380 |
Why?
|
| Rolipram | 1 | 2011 | 24 | 0.380 |
Why?
|
| Particulate Matter | 2 | 2022 | 2605 | 0.380 |
Why?
|
| Rats | 26 | 2018 | 23741 | 0.380 |
Why?
|
| Neutrophil Infiltration | 3 | 2016 | 390 | 0.370 |
Why?
|
| Homeostasis | 3 | 2020 | 3323 | 0.360 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3549 | 0.360 |
Why?
|
| Neutrophils | 9 | 2019 | 3767 | 0.360 |
Why?
|
| Mice, Knockout | 16 | 2020 | 14417 | 0.350 |
Why?
|
| Male | 75 | 2024 | 360846 | 0.350 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1359 | 0.340 |
Why?
|
| Cell Division | 9 | 2021 | 4465 | 0.340 |
Why?
|
| Influenza, Human | 2 | 2023 | 1521 | 0.340 |
Why?
|
| Macrophages, Alveolar | 7 | 2020 | 412 | 0.340 |
Why?
|
| Disease Models, Animal | 18 | 2024 | 18255 | 0.340 |
Why?
|
| Pneumonia, Viral | 2 | 2018 | 3206 | 0.330 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 2421 | 0.330 |
Why?
|
| Viral Proteins | 1 | 2016 | 1804 | 0.320 |
Why?
|
| Proteins | 10 | 2003 | 6032 | 0.320 |
Why?
|
| RNA, Messenger | 13 | 2021 | 12794 | 0.320 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 88 | 0.310 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 341 | 0.300 |
Why?
|
| Interleukin-18 | 2 | 2007 | 250 | 0.300 |
Why?
|
| Mitochondria | 2 | 2020 | 3624 | 0.300 |
Why?
|
| Cell Nucleus | 3 | 2013 | 2910 | 0.300 |
Why?
|
| Calcium | 4 | 2017 | 5722 | 0.280 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1516 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2006 | 4514 | 0.280 |
Why?
|
| Matrix Metalloproteinase 8 | 2 | 2019 | 56 | 0.280 |
Why?
|
| Cells, Cultured | 15 | 2020 | 18966 | 0.280 |
Why?
|
| Quality of Life | 3 | 2022 | 13367 | 0.270 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2005 | 273 | 0.270 |
Why?
|
| Female | 60 | 2024 | 392705 | 0.260 |
Why?
|
| Middle Aged | 39 | 2024 | 220921 | 0.260 |
Why?
|
| Respiratory Tract Diseases | 2 | 2024 | 750 | 0.260 |
Why?
|
| Horse Diseases | 1 | 2006 | 55 | 0.260 |
Why?
|
| Lung Diseases | 2 | 2014 | 1909 | 0.250 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1853 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2014 | 8554 | 0.250 |
Why?
|
| Inflammation Mediators | 5 | 2016 | 1886 | 0.250 |
Why?
|
| Carbon Monoxide | 3 | 2022 | 547 | 0.240 |
Why?
|
| Nasal Sprays | 1 | 2024 | 24 | 0.240 |
Why?
|
| Organ Culture Techniques | 3 | 2018 | 795 | 0.240 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 699 | 0.240 |
Why?
|
| Respiratory Function Tests | 7 | 2024 | 1682 | 0.230 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2013 | 302 | 0.230 |
Why?
|
| Rats, Inbred BN | 5 | 2008 | 231 | 0.230 |
Why?
|
| Aged | 33 | 2024 | 169310 | 0.230 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2016 | 44 | 0.220 |
Why?
|
| Cell Count | 5 | 2015 | 1835 | 0.220 |
Why?
|
| Inhalation Exposure | 6 | 2018 | 432 | 0.220 |
Why?
|
| Blotting, Western | 6 | 2011 | 5035 | 0.220 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 7 | 2003 | 15 | 0.210 |
Why?
|
| Peptides | 5 | 2017 | 4358 | 0.210 |
Why?
|
| Sugar Alcohols | 1 | 2022 | 18 | 0.210 |
Why?
|
| Retinoids | 3 | 2000 | 99 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2019 | 15936 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1809 | 0.210 |
Why?
|
| Exocrine Glands | 1 | 2002 | 46 | 0.200 |
Why?
|
| Endothelium, Corneal | 1 | 2024 | 215 | 0.200 |
Why?
|
| Cross-Sectional Studies | 8 | 2024 | 26129 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 461 | 0.200 |
Why?
|
| Protein Biosynthesis | 5 | 1996 | 2112 | 0.200 |
Why?
|
| Risk Factors | 18 | 2024 | 74213 | 0.200 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 12059 | 0.200 |
Why?
|
| Obesity | 2 | 2014 | 12947 | 0.190 |
Why?
|
| Environmental Exposure | 3 | 2018 | 4485 | 0.190 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2015 | 412 | 0.190 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2019 | 145 | 0.190 |
Why?
|
| Respiratory System | 3 | 2021 | 563 | 0.190 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 12690 | 0.180 |
Why?
|
| Airway Obstruction | 1 | 2006 | 661 | 0.180 |
Why?
|
| Antiporters | 1 | 2022 | 277 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
| Mortality | 2 | 2024 | 2902 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 390 | 0.180 |
Why?
|
| Adult | 29 | 2024 | 221210 | 0.180 |
Why?
|
| Cystic Fibrosis | 2 | 2012 | 1285 | 0.180 |
Why?
|
| Air Pollution | 2 | 2005 | 2359 | 0.170 |
Why?
|
| Chemokines | 3 | 2015 | 959 | 0.170 |
Why?
|
| Disease Progression | 6 | 2021 | 13510 | 0.170 |
Why?
|
| Time Factors | 8 | 2016 | 39969 | 0.160 |
Why?
|
| Peptide Biosynthesis | 3 | 1993 | 52 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10194 | 0.160 |
Why?
|
| Logistic Models | 5 | 2018 | 13255 | 0.160 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 151 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 418 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2020 | 174 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 3 | 1997 | 1062 | 0.150 |
Why?
|
| Pancreatic Elastase | 1 | 2018 | 127 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 471 | 0.150 |
Why?
|
| Intermediate Filament Proteins | 1 | 1999 | 262 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 17904 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 98 | 0.150 |
Why?
|
| Cricetinae | 5 | 2003 | 2423 | 0.150 |
Why?
|
| Epithelium | 7 | 1998 | 1603 | 0.150 |
Why?
|
| Gases | 1 | 2018 | 204 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3597 | 0.140 |
Why?
|
| Swine | 7 | 1996 | 5915 | 0.140 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15843 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 92 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 1010 | 0.140 |
Why?
|
| Species Specificity | 2 | 2015 | 2414 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 505 | 0.140 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 915 | 0.130 |
Why?
|
| NF-kappa B | 4 | 2023 | 2490 | 0.130 |
Why?
|
| Virus Replication | 3 | 2023 | 2435 | 0.130 |
Why?
|
| Endophenotypes | 1 | 2018 | 255 | 0.130 |
Why?
|
| CHO Cells | 4 | 2003 | 1387 | 0.130 |
Why?
|
| Cohort Studies | 10 | 2024 | 41495 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 422 | 0.130 |
Why?
|
| Fever | 5 | 2002 | 1618 | 0.130 |
Why?
|
| Gene Silencing | 2 | 2013 | 1509 | 0.130 |
Why?
|
| Markov Chains | 2 | 2016 | 966 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2018 | 4001 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2018 | 1007 | 0.130 |
Why?
|
| Multigene Family | 1 | 1999 | 1076 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5799 | 0.120 |
Why?
|
| Aerosols | 3 | 2011 | 635 | 0.120 |
Why?
|
| Linear Models | 2 | 2016 | 5872 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 604 | 0.120 |
Why?
|
| Mice, Nude | 2 | 2016 | 3614 | 0.120 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2015 | 105 | 0.120 |
Why?
|
| Comorbidity | 3 | 2018 | 10508 | 0.120 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2014 | 37 | 0.120 |
Why?
|
| Endothelium | 1 | 2017 | 765 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2014 | 53 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 540 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3801 | 0.120 |
Why?
|
| Vitamin A | 3 | 1993 | 613 | 0.120 |
Why?
|
| Molecular Sequence Data | 10 | 2004 | 17635 | 0.110 |
Why?
|
| Chick Embryo | 1 | 2016 | 982 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 10766 | 0.110 |
Why?
|
| Dyspnea | 1 | 2022 | 1347 | 0.110 |
Why?
|
| Case-Control Studies | 8 | 2020 | 22176 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 561 | 0.110 |
Why?
|
| Base Sequence | 8 | 2006 | 12441 | 0.110 |
Why?
|
| Metformin | 1 | 2021 | 906 | 0.110 |
Why?
|
| Polyvinyls | 1 | 1994 | 154 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2013 | 774 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1749 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1878 | 0.110 |
Why?
|
| Butyric Acid | 1 | 2013 | 51 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 662 | 0.110 |
Why?
|
| Phenotype | 8 | 2019 | 16592 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 372 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2002 | 3208 | 0.110 |
Why?
|
| Th2 Cells | 3 | 2008 | 1060 | 0.110 |
Why?
|
| Nicotine | 3 | 2016 | 680 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 146 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 1999 | 2748 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 1076 | 0.110 |
Why?
|
| Bezafibrate | 2 | 2003 | 14 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 579 | 0.110 |
Why?
|
| Health Status Indicators | 2 | 2018 | 970 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 1994 | 366 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 1 | 2015 | 393 | 0.100 |
Why?
|
| Sarin | 2 | 2002 | 4 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 133 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3779 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 597 | 0.100 |
Why?
|
| Dogs | 2 | 2016 | 3839 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 371 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6345 | 0.100 |
Why?
|
| Chemical Warfare Agents | 2 | 2002 | 19 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2022 | 12130 | 0.100 |
Why?
|
| Lipoxins | 1 | 2015 | 419 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 726 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2015 | 597 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4576 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2017 | 1069 | 0.100 |
Why?
|
| Proline | 1 | 1993 | 457 | 0.100 |
Why?
|
| Amino Acid Sequence | 9 | 1999 | 13446 | 0.100 |
Why?
|
| Government Regulation | 1 | 2016 | 524 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 619 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2015 | 326 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.100 |
Why?
|
| Signal Transduction | 7 | 2020 | 23447 | 0.100 |
Why?
|
| Macaca fascicularis | 3 | 2021 | 903 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2016 | 1510 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2022 | 9647 | 0.090 |
Why?
|
| Carcinogens | 3 | 2003 | 452 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2014 | 696 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4580 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2019 | 2632 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 14608 | 0.090 |
Why?
|
| Haplotypes | 4 | 2015 | 2713 | 0.090 |
Why?
|
| Proline-Rich Protein Domains | 4 | 1995 | 9 | 0.090 |
Why?
|
| Alcian Blue | 2 | 2007 | 13 | 0.090 |
Why?
|
| Periodic Acid-Schiff Reaction | 2 | 2007 | 16 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2016 | 2612 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3415 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16990 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2018 | 901 | 0.090 |
Why?
|
| Acetylation | 1 | 2013 | 1055 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 352 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 481 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2707 | 0.090 |
Why?
|
| Metabolomics | 1 | 2019 | 1659 | 0.090 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2009 | 56 | 0.090 |
Why?
|
| Genotype | 5 | 2015 | 12990 | 0.090 |
Why?
|
| Genes, p16 | 1 | 2010 | 160 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2009 | 90 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2011 | 11530 | 0.080 |
Why?
|
| Horses | 2 | 2011 | 300 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2019 | 3687 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 495 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2015 | 2639 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1616 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2017 | 1615 | 0.080 |
Why?
|
| Lactococcus lactis | 1 | 1989 | 29 | 0.080 |
Why?
|
| Gene Deletion | 1 | 1997 | 2665 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 720 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2008 | 59 | 0.080 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 53 | 0.080 |
Why?
|
| Cathepsin B | 1 | 2008 | 80 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2008 | 103 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 357 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2451 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1741 | 0.080 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2008 | 46 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2003 | 7593 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2882 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2004 | 6075 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3524 | 0.080 |
Why?
|
| Cell Cycle | 1 | 1996 | 2932 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2015 | 1067 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 532 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 515 | 0.080 |
Why?
|
| Cell Survival | 3 | 2019 | 5791 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2011 | 2601 | 0.070 |
Why?
|
| Protein Transport | 2 | 2019 | 1967 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2014 | 9319 | 0.070 |
Why?
|
| Hematoxylin | 1 | 2007 | 60 | 0.070 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2007 | 69 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2013 | 937 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2017 | 1979 | 0.070 |
Why?
|
| Hemagglutinins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2008 | 195 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 15733 | 0.070 |
Why?
|
| DNA Damage | 2 | 2014 | 2449 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 192 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 4415 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 1997 | 4937 | 0.070 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 173 | 0.070 |
Why?
|
| Ozone | 2 | 2002 | 483 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1997 | 2805 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1999 | 817 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9542 | 0.070 |
Why?
|
| Southwestern United States | 1 | 2006 | 39 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 999 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1726 | 0.060 |
Why?
|
| Eosinophils | 3 | 2013 | 950 | 0.060 |
Why?
|
| DNA Primers | 2 | 2003 | 2820 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 1996 | 2557 | 0.060 |
Why?
|
| Cyclin D1 | 2 | 1998 | 451 | 0.060 |
Why?
|
| Age Distribution | 1 | 2011 | 2879 | 0.060 |
Why?
|
| Bacteriophages | 1 | 1989 | 378 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2016 | 8321 | 0.060 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 477 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2417 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2016 | 698 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 3449 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2010 | 823 | 0.060 |
Why?
|
| Cell Line | 3 | 2016 | 15601 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 562 | 0.060 |
Why?
|
| Pedigree | 1 | 2013 | 4542 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2003 | 1463 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 1996 | 1545 | 0.060 |
Why?
|
| Models, Biological | 2 | 2013 | 9469 | 0.060 |
Why?
|
| Haplorhini | 2 | 1996 | 525 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2016 | 4125 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 347 | 0.060 |
Why?
|
| Autopsy | 1 | 2008 | 1009 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2669 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15266 | 0.060 |
Why?
|
| Escherichia coli | 1 | 1996 | 4217 | 0.060 |
Why?
|
| Macrophages | 2 | 2016 | 5767 | 0.060 |
Why?
|
| Oxidative Stress | 4 | 2017 | 3113 | 0.060 |
Why?
|
| Beryllium | 1 | 2003 | 14 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2006 | 469 | 0.060 |
Why?
|
| Kinetics | 3 | 2002 | 6374 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2007 | 1085 | 0.050 |
Why?
|
| Antioxidants | 1 | 2011 | 1668 | 0.050 |
Why?
|
| Nitrosamines | 1 | 2003 | 87 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2007 | 1416 | 0.050 |
Why?
|
| Costa Rica | 2 | 2014 | 180 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 113 | 0.050 |
Why?
|
| Ploidies | 1 | 2003 | 285 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2002 | 26 | 0.050 |
Why?
|
| Body Weight | 3 | 2002 | 4618 | 0.050 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Hypoxanthines | 1 | 2021 | 35 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 531 | 0.050 |
Why?
|
| Gene Frequency | 3 | 2015 | 3606 | 0.050 |
Why?
|
| United States | 5 | 2023 | 72340 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10721 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2065 | 0.050 |
Why?
|
| Rabbits | 3 | 1998 | 4772 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 584 | 0.050 |
Why?
|
| Body Temperature | 2 | 2002 | 781 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2002 | 129 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7048 | 0.050 |
Why?
|
| Acute Disease | 1 | 2012 | 7237 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 8075 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9420 | 0.050 |
Why?
|
| Papio papio | 1 | 2021 | 3 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2005 | 1149 | 0.050 |
Why?
|
| Benzo(a)pyrene | 1 | 2001 | 27 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2004 | 1596 | 0.050 |
Why?
|
| Cytosol | 2 | 2013 | 888 | 0.050 |
Why?
|
| Pigmentation | 1 | 2002 | 144 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2002 | 105 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 2 | 2001 | 552 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2006 | 1036 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2021 | 174 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 10451 | 0.050 |
Why?
|
| Persian Gulf Syndrome | 1 | 2001 | 48 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.050 |
Why?
|
| Dissection | 1 | 2002 | 298 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 1996 | 1900 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1995 | 2186 | 0.050 |
Why?
|
| Bronchitis | 1 | 2001 | 196 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 18399 | 0.050 |
Why?
|
| Eosinophilia | 2 | 2002 | 560 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 242 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2010 | 6345 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1762 | 0.040 |
Why?
|
| Receptors, Cholinergic | 1 | 2001 | 244 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2001 | 701 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 21355 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2002 | 410 | 0.040 |
Why?
|
| P-Selectin | 1 | 2002 | 597 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2561 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 427 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 879 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2017 | 12953 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 2467 | 0.040 |
Why?
|
| Capsaicin | 1 | 2001 | 231 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 11076 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 224 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 36193 | 0.040 |
Why?
|
| Protein Binding | 1 | 2012 | 9353 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1903 | 0.040 |
Why?
|
| Endotoxins | 1 | 2002 | 520 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2457 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2477 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 1036 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2747 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1248 | 0.040 |
Why?
|
| Epidemics | 1 | 2024 | 512 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4434 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 15502 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2021 | 2677 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2003 | 609 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2000 | 587 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 1999 | 95 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 602 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 365 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 498 | 0.040 |
Why?
|
| Immune System | 2 | 2001 | 796 | 0.040 |
Why?
|
| Household Products | 1 | 2018 | 27 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 244 | 0.040 |
Why?
|
| Cecum | 1 | 1998 | 233 | 0.040 |
Why?
|
| Particle Size | 1 | 2002 | 1648 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4920 | 0.040 |
Why?
|
| Carbon | 1 | 2001 | 666 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39106 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 799 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6214 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 246 | 0.030 |
Why?
|
| Larynx | 1 | 2002 | 492 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1997 | 70 | 0.030 |
Why?
|
| Transfection | 2 | 2003 | 5774 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6131 | 0.030 |
Why?
|
| Nociceptors | 1 | 2001 | 461 | 0.030 |
Why?
|
| Down-Regulation | 3 | 2015 | 2919 | 0.030 |
Why?
|
| DNA | 3 | 2003 | 7213 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2016 | 83 | 0.030 |
Why?
|
| Plants, Toxic | 1 | 1996 | 71 | 0.030 |
Why?
|
| Sex Factors | 1 | 2010 | 10554 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 1023 | 0.030 |
Why?
|
| Animal Experimentation | 1 | 2016 | 46 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2001 | 656 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 80 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2002 | 4352 | 0.030 |
Why?
|
| Mecamylamine | 1 | 2015 | 27 | 0.030 |
Why?
|
| Nuclear Matrix | 1 | 1995 | 30 | 0.030 |
Why?
|
| Epidermis | 1 | 1999 | 528 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 574 | 0.030 |
Why?
|
| Cooking | 1 | 2018 | 315 | 0.030 |
Why?
|
| Spleen | 1 | 2001 | 2295 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2015 | 45 | 0.030 |
Why?
|
| G1 Phase | 1 | 1996 | 403 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2019 | 549 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2015 | 30 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 541 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4243 | 0.030 |
Why?
|
| Eating | 1 | 2001 | 1539 | 0.030 |
Why?
|
| Heterozygote | 1 | 2001 | 2787 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20568 | 0.030 |
Why?
|
| Cyclins | 1 | 1997 | 594 | 0.030 |
Why?
|
| Fibrinolysin | 1 | 2014 | 131 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 95 | 0.030 |
Why?
|
| Keratins | 1 | 2015 | 498 | 0.030 |
Why?
|
| Methylation | 1 | 1997 | 1084 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2201 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 54423 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2001 | 1199 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58984 | 0.030 |
Why?
|
| Azacitidine | 2 | 2011 | 336 | 0.030 |
Why?
|
| Equipment Design | 1 | 2002 | 3511 | 0.030 |
Why?
|
| Bucladesine | 1 | 1993 | 118 | 0.030 |
Why?
|
| Mesocricetus | 1 | 1993 | 252 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 421 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8466 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 1646 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1704 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29629 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 999 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 1997 | 672 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4281 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1993 | 813 | 0.030 |
Why?
|
| Child | 5 | 2024 | 80158 | 0.030 |
Why?
|
| Aldehydes | 1 | 2013 | 170 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 719 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6864 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2856 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 1058 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2161 | 0.020 |
Why?
|
| DNA Ligases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Aging | 2 | 2022 | 8710 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 945 | 0.020 |
Why?
|
| Oncogenes | 1 | 1997 | 1222 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 88 | 0.020 |
Why?
|
| Motor Activity | 1 | 2001 | 2715 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 148 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 170 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Mesothelioma | 1 | 1997 | 807 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 373 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 1997 | 4615 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2139 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1993 | 416 | 0.020 |
Why?
|
| Drug Design | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Cell Movement | 1 | 2003 | 5205 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2518 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3420 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1990 | 340 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1992 | 638 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11742 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 360 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 945 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14665 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 2011 | 160 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 459 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 897 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2024 | 42232 | 0.020 |
Why?
|
| Biomedical Research | 2 | 2017 | 3429 | 0.020 |
Why?
|
| Ambrosia | 1 | 2008 | 6 | 0.020 |
Why?
|
| Immunoglobulin E | 2 | 2008 | 1502 | 0.020 |
Why?
|
| Antibodies | 1 | 1996 | 2418 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Leukotriene C4 | 1 | 2008 | 79 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 20100 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 1998 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2008 | 190 | 0.020 |
Why?
|
| Young Adult | 3 | 2024 | 59260 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1659 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1664 | 0.020 |
Why?
|
| Adolescent | 3 | 2024 | 88326 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13642 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2001 | 3980 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2008 | 4544 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1996 | 5870 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2026 | 0.020 |
Why?
|
| Fruit | 1 | 2011 | 1160 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 1195 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2264 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2048 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12723 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 1371 | 0.020 |
Why?
|
| Skin | 1 | 1999 | 4484 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 57 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9610 | 0.010 |
Why?
|
| International Cooperation | 1 | 2011 | 1422 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3430 | 0.010 |
Why?
|
| Sepsis | 1 | 1998 | 2585 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 243 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 5112 | 0.010 |
Why?
|
| Bronchiolitis, Viral | 1 | 2004 | 82 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8633 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 48 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2003 | 41 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 309 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2735 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 30053 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3492 | 0.010 |
Why?
|
| Turpentine | 1 | 2002 | 10 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9610 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2004 | 728 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 2002 | 156 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3605 | 0.010 |
Why?
|
| Macaca mulatta | 3 | 1993 | 2329 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 157 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2001 | 77 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2001 | 106 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2001 | 216 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2001 | 220 | 0.010 |
Why?
|
| Solvents | 1 | 2002 | 295 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 221 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2001 | 149 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6484 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2001 | 361 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3517 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 698 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 728 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 413 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2000 | 190 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 390 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64685 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 406 | 0.010 |
Why?
|
| Denervation | 1 | 2001 | 265 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2001 | 298 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2001 | 227 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4425 | 0.010 |
Why?
|
| Lymphocyte Activation | 2 | 2001 | 5485 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2000 | 198 | 0.010 |
Why?
|
| Exploratory Behavior | 1 | 2001 | 279 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5821 | 0.010 |
Why?
|
| Exons | 2 | 1997 | 2391 | 0.010 |
Why?
|
| Corticosterone | 1 | 2000 | 305 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2875 | 0.010 |
Why?
|
| Pregnancy | 2 | 2015 | 29890 | 0.010 |
Why?
|
| Peritonitis | 1 | 2001 | 368 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 8181 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 225 | 0.010 |
Why?
|
| Peroxidase | 1 | 2001 | 609 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2000 | 1157 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2006 | 2767 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 2000 | 346 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 80647 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 321 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 2000 | 182 | 0.010 |
Why?
|
| Ligation | 1 | 1998 | 448 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 1997 | 84 | 0.010 |
Why?
|
| Punctures | 1 | 1998 | 366 | 0.010 |
Why?
|
| Foot | 1 | 2001 | 575 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1227 | 0.010 |
Why?
|
| Cell Physiological Phenomena | 1 | 1997 | 150 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6534 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1869 | 0.010 |
Why?
|
| Atrophy | 1 | 2001 | 1633 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 3332 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 2112 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2001 | 1152 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 221 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5305 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 851 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1494 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1993 | 287 | 0.010 |
Why?
|
| CpG Islands | 1 | 1997 | 1230 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14033 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 777 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4174 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3713 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 2425 | 0.010 |
Why?
|
| Introns | 1 | 1993 | 981 | 0.010 |
Why?
|
| Karyotyping | 1 | 1992 | 1171 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1998 | 1391 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1202 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1993 | 3094 | 0.000 |
Why?
|
| Liver | 1 | 2002 | 7528 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 2000 | 2894 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4740 | 0.000 |
Why?
|
| Brain | 2 | 2002 | 27121 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4024 | 0.000 |
Why?
|
| Binding Sites | 1 | 1993 | 6056 | 0.000 |
Why?
|